Latest XVIVO News & Updates

See the latest news and media coverage for XVIVO. We track all announcements, press releases, and industry mentions in real time, all in one place.

XVIVO

Organ transplantation technology company

xvivogroup.com

Headquarters: Mölndal, Sweden
Founded year: 1998
Company type: Public company
Number of employees: 50–300
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about XVIVO

In short: XVIVO secured CE certification for its heart preservation technology and achieved significant organic growth in its 2026 financial results.

Company announcements

August 21 XVIVO

XVIVO announces NHS integration of liver machine perfusion guidance

UK health authorities now fund the device through core budgets, recognizing its clinical benefits and support for multiple preservation strategies.

August 11 XVIVO

XVIVO receives CE certificates for its heart preservation technology

The XVIVO Heart Assist Transport system uses HOPE to extend preservation time, reducing severe complications by 38% and improving survival rates.

August 3 XVIVO

XVIVO granted additional patient enrollment in PRESERVE CAP study

FDA approval enables continued enrollment in CAP study of 60 heart transplantations using XVIVO Heart Assist Transport, with CMS cost recovery support.

July 14 XVIVO

XVIVO's net sales grew 34 percent in Q2

EBITDA margin improved to 19 percent, cash flow from operations was SEK 63.5 million.

Media coverage

September 10 ZoneBourse

AQR, new declared short seller at Xvivo Perfusion

AQR Capital Management has taken a public short position of 0.50% in the medical technology company Xvivo Perfusion, which corresponds...

August 20 FinanzNachrichten.de

XVIVO receives CE certificates for groundbreaking heart preservation technology

Gothenburg/Berlin (ots) - - The CE certifications enable the broader use of the innovative XVIVO technology and improve access to heart transplants in Europe. XVIVO gives the CE mark...

August 10 Dagens industri

Bure-owned company surges after 'regulatory milestone'

Bure-owned transplantation company Xvivo Perfusion surges on the stock exchange after the company received CE certification for its heart-preserving technology. The system is...

August 2 Yahoo Finance

XVIVO Granted Additional Patient Enrollment in the US PRESERVE CAP Study for XVIVO Heart Assist Transport

GOTHENBURG, SE / ACCESS Newswire / August 3, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - XVIVO announces that the US Food and Drug Administration (FDA...

Never miss news about XVIVO

Track XVIVO and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

XVIVO competitors & trending companies

Browse news for competitors to XVIVO and other trending companies.